메뉴 건너뛰기




Volumn 72, Issue 1, 2009, Pages 18-22

Additive beneficial effects of beta blockers in the prevention of symptomatic heart failure

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CARVEDILOL; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; HYDROCHLOROTHIAZIDE; METOPROLOL; PINDOLOL; PROPRANOLOL DERIVATIVE;

EID: 69849134125     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (5)

References (36)
  • 1
    • 28744446343 scopus 로고    scopus 로고
    • ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure)
    • American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society
    • Hunt SA, Abraham WT, Chin MH, et al. American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005; 112e: 154-235.
    • (2005) Circulation , vol.112 E , pp. 154-235
    • Hunt, S.A.1    Abraham, W.T.2    Chin, M.H.3
  • 3
    • 0029960897 scopus 로고    scopus 로고
    • Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials
    • DOI 10.1016/0735-1097(95)00606-0
    • Moser M, Herbert PR. Prevention of Disease Progression, Left Ventricular Hypertrophy and Congestive Heart Failure in Hypertension Treatment Trials. J Am Coll Cardiol 1996; 271: 214-218 (Pubitemid 26117716)
    • (1996) Journal of the American College of Cardiology , vol.27 , Issue.5 , pp. 1214-1218
    • Moser, M.1    Hebert, P.R.2
  • 4
    • 0025043248 scopus 로고
    • Blood pressure and coronary heart disease
    • DOI 10.1016/0140-6736(90)91908-S
    • Collins R, Peto R, MacMahon S et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-838. (Pubitemid 20264177)
    • (1990) Lancet , vol.336 , Issue.8711 , pp. 370-371
    • Collins, R.1    Peto, R.2    Godwin, J.3    MacMahon, S.4
  • 5
    • 0025942936 scopus 로고
    • Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
    • Dahlöf B, Lindholm LH, Hansson L, Scherstén B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-1285.
    • (1991) Lancet , vol.338 , pp. 1281-1285
    • Dahlöf, B.1    Lindholm, L.H.2    Hansson, L.3    Scherstén, B.4    Ekbom, T.5    Wester, P.O.6
  • 7
    • 0033589756 scopus 로고    scopus 로고
    • Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
    • for the STOP-Hypertension-2 study group
    • Hansson L, Lindholm LH, Ekbom T et al for the STOP-Hypertension-2 study group Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study Lancet; 354, 751-1756.
    • Lancet , vol.354 , pp. 751-1756
    • Hansson, L.1    Lindholm, L.H.2    Ekbom, T.3
  • 8
    • 0242654867 scopus 로고    scopus 로고
    • Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomised trials
    • Blood Pressure Lowering Treatment Trialists' Collaboration
    • Blood Pressure Lowering Treatment Trialists' Collaboration Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003; 362: 1527-1535.
    • (2003) Lancet , vol.362 , pp. 1527-1535
  • 11
    • 0038642326 scopus 로고    scopus 로고
    • A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension
    • DOI 10.1016/S0002-9343(03)00158-X
    • Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med 2003; 115: 41-46 (Pubitemid 36831120)
    • (2003) American Journal of Medicine , vol.115 , Issue.1 , pp. 41-46
    • Klingbeil, A.U.1    Schneider, M.2    Martus, P.3    Messerli, F.H.4    Schmieder, R.E.5
  • 12
    • 0037160968 scopus 로고    scopus 로고
    • Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
    • LIFE Study Group
    • Dahlöf B, Devereux RB, Kjeldsen SE, et al. LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 995-1003.
    • (2002) Lancet , vol.359 , pp. 995-1003
    • Dahlöf, B.1    Devereux, R.B.2    Kjeldsen, S.E.3
  • 13
    • 0043025552 scopus 로고    scopus 로고
    • Heart Failure: The frequent, forgotten, and often fatal complication of diabetes
    • Bell SH. Heart Failure: The frequent, forgotten, and often fatal complication of diabetes. Diabetes Care 2003; 26: 2433-2441.
    • (2003) Diabetes Care , vol.26 , pp. 2433-2441
    • Bell, S.H.1
  • 14
    • 0030744746 scopus 로고    scopus 로고
    • Congestive heart failure predicts the development of non-insulin- dependent diabetes mellitus in the elderly: The Osservatorio Geriatrico Regione Campania Group
    • Amato L, Paolisso G, Cacciatore F et al. Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly: the Osservatorio Geriatrico Regione Campania Group. Diabetes Metab 1997; 23: 213-218.
    • (1997) Diabetes Metab , vol.23 , pp. 213-218
    • Amato, L.1    Paolisso, G.2    Cacciatore, F.3
  • 16
    • 0019459311 scopus 로고
    • Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction
    • Norwegian Multicentre Study Group
    • Norwegian Multicentre Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981; 304: 801-807.
    • (1981) N Engl J Med , vol.304 , pp. 801-807
  • 17
    • 0020078179 scopus 로고
    • A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results
    • BHAT Research Group
    • (BHAT Research Group). A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 1982; 247: 1707-1714.
    • (1982) JAMA , vol.247 , pp. 1707-1714
  • 18
    • 0021038370 scopus 로고
    • A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results
    • BHAT Research Group
    • (BHAT Research Group). A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results. JAMA 1983; 250: 2814-2819.
    • (1983) JAMA , vol.250 , pp. 2814-2819
  • 19
    • 27644531361 scopus 로고    scopus 로고
    • Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: Randomised placebo-controlled trial
    • COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group
    • Chen ZM, Pan HC, Chen YP, et al. COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005; 366: 1622-1632.
    • (2005) Lancet , vol.366 , pp. 1622-1632
    • Chen, Z.M.1    Pan, H.C.2    Chen, Y.P.3
  • 20
    • 0000093848 scopus 로고    scopus 로고
    • β blockade after myocardial infarction: Systematic review and meta regression analysis
    • Freemantle N, Cleland J, Young P, Mason J, Harrison J. Beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 1999; 318: 1730-1737 (Pubitemid 29290470)
    • (1999) British Medical Journal , vol.318 , Issue.7200 , pp. 1730-1737
    • Freemantle, N.1    Cleland, J.2    Young, P.3    Mason, J.4    Harrison, J.5
  • 21
    • 0034614172 scopus 로고    scopus 로고
    • Health and economic benefits of increased beta-blocker use following myocardial infarction
    • Phillips KA, Shlipak MG, Coxson P, et al. Health and economic benefits of increased beta-blocker use following myocardial infarction. JAMA 2000; 284: 2748-2754.
    • (2000) JAMA , vol.284 , pp. 2748-2754
    • Phillips, K.A.1    Shlipak, M.G.2    Coxson, P.3
  • 22
    • 0030660245 scopus 로고    scopus 로고
    • Mechanism of Action of Beta-Blocking Agents in Heart Failure
    • Bristow MR. Mechanism of Action of Beta-Blocking Agents in Heart Failure. Am J Cardiol 1997; 80 (11A): 26L-40L.
    • (1997) Am J Cardiol , vol.80 , Issue.11 A
    • Bristow, M.R.1
  • 23
    • 0033549290 scopus 로고    scopus 로고
    • Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
    • MERIT-HF Study Group
    • MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353: 2001-2007.
    • (1999) Lancet , vol.353 , pp. 2001-2007
  • 24
    • 0033514046 scopus 로고    scopus 로고
    • The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
    • CIBIS-II Investigators and Committees
    • The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial CIBIS-II Investigators and Committees. Lancet 1999 353: 9-13.
    • (1999) Lancet , vol.353 , pp. 9-13
  • 25
    • 0035978763 scopus 로고    scopus 로고
    • Effect of carvedilol on survival in severe chronic heart failure
    • Carvedilol Prospective Randomized Cumulative Survival Study Group
    • Packer M, Coats AJ, Fowler MB, et al. Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344: 1651-1826.
    • (2001) N Engl J Med , vol.344 , pp. 1651-1826
    • Packer, M.1    Coats, A.J.2    Fowler, M.B.3
  • 27
    • 0031050642 scopus 로고    scopus 로고
    • Randomized placebo controlled trial of carvedilol in patients with congestive heart failure due to ischemic heart disease
    • Australia New Zealand Heart Failure Collaborative Research Group
    • Australia New Zealand Heart Failure Collaborative Research Group. Randomized placebo controlled trial of carvedilol in patients with congestive heart failure due to ischemic heart disease. Lancet 1997; 349: 375-380.
    • (1997) Lancet , vol.349 , pp. 375-380
  • 28
    • 0026786643 scopus 로고
    • Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial
    • The SAVE Investigators
    • Pfeffer MA, Braunwald E, Moyé LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 1992; 327: 69-77.
    • (1992) N Engl J Med , vol.327 , pp. 69-77
    • Pfeffer, M.A.1    Braunwald, E.2    Moyé, L.A.3
  • 30
    • 0035810547 scopus 로고    scopus 로고
    • Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomised trial
    • Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001; 357: 1385-1390.
    • (2001) Lancet , vol.357 , pp. 1385-1390
    • Dargie, H.J.1
  • 31
    • 1642494797 scopus 로고    scopus 로고
    • Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: The CAPRICORN Echo Sub-study
    • CAPRICORN Echo Sub-study Investigators. 20
    • Doughty RN, Whalley GA, Walsh HA, Gamble GD, López-Sendón J, Sharpe N. CAPRICORN Echo Sub-study Investigators. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Sub-study. Circulation 2004: 20; 109: 201-206
    • (2004) Circulation , vol.109 , pp. 201-206
    • Doughty, R.N.1    Whalley, G.A.2    Walsh, H.A.3    Gamble, G.D.4    López- Sendón, J.5    Sharpe, N.6
  • 32
    • 0035581276 scopus 로고    scopus 로고
    • Effect of beta blockers alone, of angiotensin-converting enzyme inhibitors alone, and of beta blockers plus angiotensin-converting enzyme inhibitors on new coronary events and on congestive heart failure in older persons with healed myocardial infarcts and asymptomatic left ventricular systolic dysfunction
    • DOI 10.1016/S0002-9149(01)02092-6, PII S0002914901020926
    • Aronow WS, Ahn C, Kronzon I. Effect of beta blockers alone, of angiotensin-converting enzyme inhibitors alone, and of beta blockers plus angiotensin-converting enzyme inhibitors on new coronary events and on congestive heart failure in older persons with healed myocardial infarcts and asymptomatic left ventricular systolic dysfunction. Am J Cardiol 2001; 88: 1298-1300. (Pubitemid 33132100)
    • (2001) American Journal of Cardiology , vol.88 , Issue.11 , pp. 1298-1300
    • Aronow, W.S.1    Ahn, C.2    Kronzon, I.3
  • 33
    • 0026785561 scopus 로고
    • Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
    • The SOLVD Investigators 10
    • The SOLVD Investigators Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992: 10; 327: 1768.
    • (1992) N Engl J Med , vol.327 , pp. 1768
  • 34
    • 0033558687 scopus 로고    scopus 로고
    • Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A post hoc analysis of the Studies of Left Ventricular Dysfunction
    • Exner DV, Dries DL, Waclawiw MA, Shelton B, Domanski MJ. Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1999; 33: 916-923
    • (1999) J Am Coll Cardiol , vol.33 , pp. 916-923
    • Exner, D.V.1    Dries, D.L.2    Waclawiw, M.A.3    Shelton, B.4    Domanski, M.J.5
  • 35
    • 34347361610 scopus 로고    scopus 로고
    • Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: The REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial
    • REVERT Study Group. Jul 3
    • Colucci WS, Kolias TJ, Adams KF, et al. REVERT Study Group. Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial. Circulation 2007 Jul 3; 116(1): 49-56.
    • (2007) Circulation , vol.116 , Issue.1 , pp. 49-56
    • Colucci, W.S.1    Kolias, T.J.2    Adams, K.F.3
  • 36
    • 3342943389 scopus 로고    scopus 로고
    • The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN)
    • Remme WJ, Riegger G, Hildebrandt P, et al. The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN). Cardiovasc Drugs Ther 2004; 18: 57-66.
    • (2004) Cardiovasc Drugs Ther , vol.18 , pp. 57-66
    • Remme, W.J.1    Riegger, G.2    Hildebrandt, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.